Across the world, the proportions of senior citizens (ie those≥ 65 years) increase rapidly
and are predicted to constitute over 25% of the general population by 2050. In 2012 already
48% of the population with end stage renal disease (ESRD) was aged 65 years or older.
Transplantation is considered the preferred treatment option for ESRD offering survival
advantage over long-term dialysis in the majority of patients. Indeed, acceptable outcomes
have been documented for selected patients over the age of 70 years or even cases over 80 …